{"url":"https://lda.senate.gov/api/v1/filings/78b4ccbc-ffb5-4c8d-a8ed-ebe16ed3b5a2/","filing_uuid":"78b4ccbc-ffb5-4c8d-a8ed-ebe16ed3b5a2","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2018,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.senate.gov/filings/public/filing/78b4ccbc-ffb5-4c8d-a8ed-ebe16ed3b5a2/print/","filing_document_content_type":"text/html","income":"60000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Timothy F. Hannegan","dt_posted":"2018-04-18T14:32:05.810000-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"101 Constitution Avenue, NW","registrant_address_2":"Suite L110","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20001","registrant":{"id":400918672,"url":"https://lda.senate.gov/api/v1/registrants/400918672/","house_registrant_id":42026,"name":"PENN AVENUE PARTNERS","description":"​Government Affairs.","address_1":"701 Pennsylvania Avenue, NW","address_2":"Suite 230","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20004","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"BETH ANNE COLE","contact_telephone":"+1 202-256-5643","dt_updated":"2026-01-27T13:57:41.474980-05:00"},"client":{"id":196187,"url":"https://lda.senate.gov/api/v1/clients/196187/","client_id":505,"name":"PURDUE PHARMA L.P.","general_description":"Pharmaceutical company.","client_government_entity":false,"client_self_select":null,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"CT","ppb_state_display":"Connecticut","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2017-04-07"},"lobbying_activities":[{"general_issue_code":"PHA","general_issue_code_display":"Pharmacy","description":"Monitoring legislative and regulatory activities impacting the pharmaceutical industry.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":56689,"prefix":"mr","prefix_display":"MR.","first_name":"TIMOTHY","nickname":null,"middle_name":"FARRELL","last_name":"HANNEGAN","suffix":null,"suffix_display":null},"covered_position":"U.S. General Accounting Office","new":false}],"government_entities":[{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}